AA
Ankit Agrawal
About Ankit Agrawal
Data last updated:
Ankit Agrawal is a Director at Jsbm Pharma Private Limited (since 2021) and Director at Fair Deal Remedies Private Limited (since 2009). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.23 Cr; the largest is Jsbm Pharma Private Limited at ₹80.7 Lakh (FY 2025). Earlier, Ankit Agrawal was a Director at Fair Deal Global Laboratories India Private Limited (from 2013) and Director at Ubiford Pharma India Private Limited (from 2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Oct 2021 | 2021 | ₹80.7 Lakh (FY 2025) | Active | |
| Director | 25 Aug 2009 | 2009 | ₹42.5 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jun 2013 | 2013 | Strike Off | ||
| Director | 27 Jun 2020 | 2020 | Strike Off | ||
| Director | 01 Apr 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ankit Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Barkha Agarwal | 09382122 | Jsbm Pharma Private Limited | Director |
| Rani Agrawal | 09382123 | Jsbm Pharma Private Limited | Director |
| Sumit Agrawal | 02471640 | Jsbm Pharma Private Limited , Fair Deal Remedies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Agrawal
Ankit Agrawal currently holds 2 directorships: Jsbm Pharma Private Limited (Director, since 29 Oct 2021, revenue ₹80.7 Lakh (FY 2025)); Fair Deal Remedies Private Limited (Director, since 25 Aug 2009, revenue ₹42.5 Lakh (FY 2025)).
Ankit Agrawal was first appointed on 25 Aug 2009 as Director at Fair Deal Remedies Private Limited. The most recent appointment on record is 29 Oct 2021 at Jsbm Pharma Private Limited.
The 2 current companies of Ankit Agrawal that report revenue have a combined latest revenue of ₹1.23 Cr: Jsbm Pharma Private Limited ₹80.7 Lakh (FY 2025); Fair Deal Remedies Private Limited ₹42.5 Lakh (FY 2025).
Ankit Agrawal held 3 earlier board appointments: Fair Deal Global Laboratories India Private Limited (Director, from 26 Jun 2013); Ubiford Pharma India Private Limited (Director, from 27 Jun 2020); Alchemist Research And Lab Private Limited (Director, from 01 Apr 2019).
The current boards of Ankit Agrawal's companies include Barkha Agarwal (Jsbm Pharma Private Limited), Rani Agrawal (Jsbm Pharma Private Limited), Sumit Agrawal (Jsbm Pharma Private Limited).